{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:22:42Z","timestamp":1789514562867,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013220","name":"Ultragenyx Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013220","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.omtm.2022.01.007","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T13:57:48Z","timestamp":1642600668000},"page":"292-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Prednisolone reduces the interferon response to AAV in cynomolgus macaques and may increase liver gene expression"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9347-3939","authenticated-orcid":false,"given":"Lili","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3659-2867","authenticated-orcid":false,"given":"Claude C.","family":"Warzecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3102-2774","authenticated-orcid":false,"given":"Alexander","family":"Kistner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Chichester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7044-3964","authenticated-orcid":false,"given":"Elizabeth L.","family":"Buza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenning","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Betina","family":"Pampena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2378-4595","authenticated-orcid":false,"given":"Julien","family":"Couthouis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunjay","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"McKeever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Betts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emil","family":"Kakkis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9630-3131","authenticated-orcid":false,"given":"James M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Wadsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0969-6131","authenticated-orcid":false,"given":"Barbara A.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2022.01.007_bib1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ymgme.2013.07.008","article-title":"The incidence of urea cycle disorders","volume":"110","author":"Summar","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2022.01.007_bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13023-015-0266-1","article-title":"Long-term outcomes in ornithine transcarbamylase deficiency: a series of 90 patients","volume":"10","author":"Brassier","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.omtm.2022.01.007_bib3","article-title":"Mutation spectrum and genotype\u2013phenotype correlation in a cohort of argentine patients with ornithine transcarbamylase deficiency: a single-center experience","volume":"6","author":"Lar\u00f3vere","year":"2018","journal-title":"J.\u00a0Inborn Errors Metab. Screen."},{"key":"10.1016\/j.omtm.2022.01.007_bib4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/adc.84.1.84","article-title":"Ornithine carbamoyltransferase deficiency","volume":"84","author":"Wraith","year":"2001","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.omtm.2022.01.007_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ymgme.2011.10.020","article-title":"Preclinical evaluation of a clinical candidate AAV8 vector for ornithine transcarbamylase (OTC) deficiency reveals functional enzyme from each persisting vector genome","volume":"105","author":"Wang","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2022.01.007_bib7","first-page":"17","article-title":"AAV8 gene therapy as a potential treatment in adults with late-onset ornithine transcarbamylase (OTC) deficiency: updated results from a phase 1\/2 clinical trial","volume":"29","author":"Harding","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.01.007_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-3-030-27378-1_27","article-title":"Innate immune response following AAV administration","volume":"1185","author":"Dauletbekov","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.omtm.2022.01.007_bib9","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fimmu.2020.00670","article-title":"Human immune responses to adeno-associated virus (AAV) vectors","volume":"11","author":"Ronzitti","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2022.01.007_bib10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","article-title":"Immune responses to viral gene therapy vectors","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.01.007_bib11","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1172\/JCI122372","article-title":"Exposure to wild-type AAV drives distinct capsid immunity profiles in humans","volume":"128","author":"Kuranda","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2022.01.007_bib12","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.ymthe.2019.11.011","article-title":"Type I IFN sensing by cDCs and CD4+ T\u00a0cell help are both requisite for cross-priming of AAV capsid-specific CD8+ T\u00a0cells","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.01.007_bib13","first-page":"493","article-title":"Evading the immune response upon in\u00a0vivo gene therapy with viral vectors","volume":"11","author":"Sack","year":"2009","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.omtm.2022.01.007_bib14","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1089\/hum.2018.233","article-title":"Optimization of dexamethasone administration for maintaining global transduction efficacy of adeno-associated virus serotype 9","volume":"30","author":"Chai","year":"2019","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2022.01.007_bib15","first-page":"167","article-title":"The effect of prophylactic corticosteroid treatment on adeno-associated virus (AAV)-Mediated gene expression","volume":"29","author":"Handyside","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.01.007_bib16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1146\/annurev-virology-101416-041936","article-title":"Overcoming the host immune response to adeno-associated virus gene delivery vectors: the race between clearance, tolerance, neutralization, and escape","volume":"4","author":"Mingozzi","year":"2017","journal-title":"Annu. Rev. Virol."},{"key":"10.1016\/j.omtm.2022.01.007_bib17","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/mt.2009.139","article-title":"Sexually dimorphic patterns of episomal rAAV genome persistence in the adult mouse liver and correlation with hepatocellular proliferation","volume":"17","author":"Dane","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.01.007_bib18","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood-2002-09-2889","article-title":"Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway","volume":"102","author":"Davidoff","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2022.01.007_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/hum.2014.126","article-title":"Long-term sex-biased correction of circulating propionic acidemia disease markers by adeno-associated virus vectors","volume":"26","author":"Guenzel","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2022.01.007_bib20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/gt.2008.137","article-title":"Enhancing transduction of the liver by adeno-associated viral vectors","volume":"16","author":"Nathwani","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2022.01.007_bib21","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-1-4939-9139-6_20","article-title":"AAV-mediated gene delivery to the liver: overview of current technologies and methods","volume":"1950","author":"Palaschak","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.omtm.2022.01.007_bib22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jgg.2015.04.003","article-title":"Genotype-phenotype correlations in ornithine transcarbamylase deficiency: a mutation update","volume":"42","author":"Caldovic","year":"2015","journal-title":"J.\u00a0Genet. Genomics"},{"key":"10.1016\/j.omtm.2022.01.007_bib23","first-page":"18","article-title":"Methods for predicting sexual maturity in male cynomolgus macaques on the basis of age, body weight, and histologic evaluation of the testes","volume":"41","author":"Smedley","year":"2002","journal-title":"Contemp. Top. Lab. Anim. Sci."},{"key":"10.1016\/j.omtm.2022.01.007_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5625\/lar.2016.32.2.79","article-title":"Reference values of clinical pathology parameters in cynomolgus monkeys (Macaca fascicularis) used in preclinical studies","volume":"32","author":"Park","year":"2016","journal-title":"Lab. Anim. Res."},{"key":"10.1016\/j.omtm.2022.01.007_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa1908490","article-title":"Multiyear follow-up of AAV5-hFVIII-SQ gene therapy for hemophilia A","volume":"382","author":"Pasi","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2022.01.007_bib26","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1177\/0300985813516641","article-title":"Occurrence of multinucleated hepatocytes in cynomolgus monkeys (Macaca fascicularis) from different geographical regions","volume":"51","author":"Novilla","year":"2014","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.omtm.2022.01.007_bib27","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtm.2022.01.007_bib28","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1708483","article-title":"AAV5-factor VIII gene transfer in severe hemophilia A","volume":"377","author":"Rangarajan","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2022.01.007_bib29","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nbt.4182","article-title":"Meganuclease targeting of PCSK9 in macaque liver leads to stable reduction in serum cholesterol","volume":"36","author":"Wang","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtm.2022.01.007_bib30","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1182\/blood.2019004625","article-title":"BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression","volume":"137","author":"Konkle","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2022.01.007_bib31","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ymthe.2020.01.026","article-title":"Codon modification and PAMPs in clinical AAV vectors: the Tortoise or the hare?","volume":"28","author":"Wright","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.01.007_bib32","doi-asserted-by":"crossref","first-page":"e89869","DOI":"10.1371\/journal.pone.0089869","article-title":"Critical role of interferon-\u03b1 constitutively produced in human hepatocytes in response to RNA virus infection","volume":"9","author":"Tsugawa","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.omtm.2022.01.007_bib33","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.20021553","article-title":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood","volume":"197","author":"Bennett","year":"2003","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omtm.2022.01.007_bib34","first-page":"453752","article-title":"Severe hyperammonemia in late-onset ornithine transcarbamylase deficiency triggered by steroid administration","volume":"2015","author":"Gascon-Bayarri","year":"2015","journal-title":"Case Rep. Neurol. Med."},{"key":"10.1016\/j.omtm.2022.01.007_bib35","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/jp.2011.23","article-title":"Hyperammonemic coma in an ornithine transcarbamylase mutation carrier following antepartum corticosteroids","volume":"31","author":"Lipskind","year":"2011","journal-title":"J.\u00a0Perinatol."},{"key":"10.1016\/j.omtm.2022.01.007_bib36","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1365-2362.2002.00993.x","article-title":"Effects of high doses of glucocorticoids on free amino acids, ribosomes and protein turnover in human muscle","volume":"32","author":"L\u00f6fberg","year":"2002","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.omtm.2022.01.007_bib37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF01489175","article-title":"Influence of steroids on urea-cycle enzymes in chronic human liver disease","volume":"56","author":"Maier","year":"1978","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.omtm.2022.01.007_bib38","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ccc.2005.05.002","article-title":"Unmasked adult-onset urea cycle disorders in the critical care setting","volume":"21","author":"Summar","year":"2005","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.omtm.2022.01.007_bib39","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"Klein","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.omtm.2022.01.007_bib40","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.omtm.2021.09.005","article-title":"Safety and efficacy of an engineered hepatotropic AAV gene therapy for ornithine transcarbamylase deficiency in cynomolgus monkeys","volume":"23","author":"Baruteau","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2022.01.007_bib41","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1182\/blood-2011-09-377630","article-title":"AAV-mediated gene transfer in the perinatal period results in expression of FVII at levels that protect against fatal spontaneous hemorrhage","volume":"119","author":"Binny","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2022.01.007_bib42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/595830","article-title":"Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses","volume":"199","author":"Calcedo","year":"2009","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.omtm.2022.01.007_bib43","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ymthe.2006.03.008","article-title":"Analysis of tumors arising in male B6C3F1 mice with and without AAV vector delivery to liver","volume":"14","author":"Bell","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2022.01.007_bib44","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/hgtb.2018.038","article-title":"Assessment of humoral, innate, and t-cell immune responses to adeno-associated virus vectors","volume":"29","author":"Calcedo","year":"2018","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtm.2022.01.007_bib45","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.omtm.2018.10.012","article-title":"AAV8 gene therapy for crigler-najjar syndrome in macaques elicited transgene T\u00a0cell responses that are resident to the liver","volume":"11","author":"Greig","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050122000080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050122000080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:26:22Z","timestamp":1762421182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050122000080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":44,"alternative-id":["S2329050122000080"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2022.01.007","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prednisolone reduces the interferon response to AAV in cynomolgus macaques and may increase liver gene expression","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2022.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors.","name":"copyright","label":"Copyright"}]}}